Natera and Illumina settle litigation, agree mutual licence
14-05-2020
Stanford sues Natera over transplant testing patents
27-03-2019
CI Photos / Shutterstock.com
DNA testing developer Natera is suing ArcherDX, a molecular technology company, for allegedly infringing a patent related to multiplex polymerase chain reaction (PCR) technology.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Natera, ArcherDX, patent, infringement, DNA, multiplex polymerase chain reaction, multiplex PCR, U.S. District Court of Delaware
